Mouse Models of Sepsis

  • Gerd Albuszies
Part of the Basic Science for the Cardiologist book series (BASC, volume 16)


A wide array of murine models has been described for identifying pathophysiological and molecular mechanisms that underlie sepsis and septic shock. However, the investigator’s preference for a specific type of model often remains somewhat hampered since manifold aspects of physiological and technical properties have to be taken into account. Depending on the questions being asked, a standardized and simplified experimental approach or a more complex and hence putatively realistic septic challenge may be appropriate. However, even with implementation of recommended therapeutic strategies and thorough transformation of a typical clinical intensive care setting (including mechanical ventilation and invasive monitoring of organ function) into experiments in mice, the ideal model still may not exist. This chapter will review available models of murine sepsis in order to serve as guideline for experimental study design.


Septic Shock Multiple Organ Dysfunction Syndrome Cecal Ligation Intraabdominal Abscess Septic Mouse 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bone RC, Grodzin CJ, Balk RA (1997) Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112:235–243PubMedCrossRefGoogle Scholar
  2. 2.
    Bone RC (1994) Gram-positive organisms and sepsis. Arch Intern Med 154:26–34PubMedCrossRefGoogle Scholar
  3. 3.
    Bahar MA, Kilani RT, Ghahary A (2000) The spectrum of pathogenic bacteria in positive blood cultures. Microbios 103:107–117PubMedGoogle Scholar
  4. 4.
    Koch T, Geiger S, Ragaller MJ (2001) Monitoring of organ dysfunction in sepsis/systemic inflammatory response syndrome: novel strategies. J Am Soc Nephrol 12 Suppl 17:S53–S59Google Scholar
  5. 5.
    Fink MP (2001) Cytopathic hypoxia. Mitochondria] dysfunction as mechanism contributing to organ dysfunction in sepsis. Crit Care Clin 17:219–237PubMedCrossRefGoogle Scholar
  6. 6.
    Fink MP and Heard SO (1990) Laboratory models of sepsis and septic shock. J Surg Res 49:186–196PubMedCrossRefGoogle Scholar
  7. 7.
    Deitch EA (1998) Animal models of sepsis and shock: a review and lessons learned. Shock 9:1–11PubMedCrossRefGoogle Scholar
  8. 8.
    Evans GF, Snyder YM, Butler LD, et al. (1989) Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models. Circ Shock 29:279–290PubMedGoogle Scholar
  9. 9.
    Remick D, Manohar P, Bolgos G, et al. (1995) Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 4:89–95PubMedCrossRefGoogle Scholar
  10. 10.
    Abraham E, Anzueto A, Gutierrez G et al. (1998) Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet 351:929–933PubMedGoogle Scholar
  11. 11.
    Bone RC, Fisher CJ, Jr., Clemmer TP, et al. (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653–658PubMedCrossRefGoogle Scholar
  12. 12.
    Remick DG, Newcomb DE, Bolgos GL, et al. (2000) Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 13:110–116PubMedCrossRefGoogle Scholar
  13. 13.
    Zanetti G, Heumann D, Gerain J et al. (1992) Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide. J Immunol 148:1890–1897Google Scholar
  14. 14.
    Hyde SR, Stith RD, McCallum RE (1990) Mortality and bacteriology of sepsis following cecal ligation and puncture in aged mice. Infect Immun 58:619–624PubMedGoogle Scholar
  15. 15.
    Opal SM and Cohen J (1999) Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis? Crit Care Med 27:1608–1616PubMedCrossRefGoogle Scholar
  16. 16.
    Cross AS, Opal SM, Sadoff JC, Gemski P (1993) Choice of bacteria in animal models of sepsis. Infect Immun 61:2741–2747PubMedGoogle Scholar
  17. 17.
    Freise H, Bruckner UB, Spiegel HU (2001) Animal models of sepsis. J Invest Surg 14:195–212PubMedCrossRefGoogle Scholar
  18. 18.
    Bian Z, Yan ZQ, Hansson GK, et al. (2001) Activation of inducible nitric oxide synthase/nitric oxide by curli fibers leads to a fall in blood pressure during systemic Escherichia coli infection in mice. J Infect Dis 183:612–619PubMedCrossRefGoogle Scholar
  19. 19.
    Finlay-Jones JJ, Davies KV, Sturm LP, et al. (1999) Inflammatory processes in a murine model of intra-abdominal abscess formation. J Leukoc Biol 66:583–587PubMedGoogle Scholar
  20. 20.
    Stearne LE, Buijk SL, Mouton JW, Gyssens IC (2002) Effect of a single percutaneous abscess drainage puncture and imipenem therapy, alone or in combination, in treatment of mixed-infection abscesses in mice. Antimicrob Agents Chemother 46:3712–3718PubMedCrossRefGoogle Scholar
  21. 21.
    Wilkins TD, Walker CB, Nitzan D, Salyers AA (1977) Experimental infections with anaerobic bacteria in mice. J Infect Dis 135 Suppl:S13–S17PubMedCrossRefGoogle Scholar
  22. 22.
    Ashbaugh CD, Warren HB, Carey VJ, Wessels MR (1998) Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest 102:550–560PubMedCrossRefGoogle Scholar
  23. 23.
    Gibson FC, III, Onderdonk AB, Kasper DL, Tzianabos AO (1998) Cellular mechanism of intraabdominal abscess formation by Bacteroides fragilis. J Immunol 160:5000–5006PubMedGoogle Scholar
  24. 24.
    Vonk AG, Netea MG, Van Krieken JH, et al. (2002) Delayed Clearance of Intraabdominal Abscesses Caused by Candida albicans in Tumor Necrosis Factor-alpha-and Lymphotoxin-alpha-Deficient Mice. J Infect Dis 186:1815–1822PubMedCrossRefGoogle Scholar
  25. 25.
    Wichterman KA, Baue AE, Chaudry IH (1980) Sepsis and septic shock--a review of laboratory models and a proposal. J Surg Res 29:189–201PubMedCrossRefGoogle Scholar
  26. 26.
    Baker CC, Chaudry IH, Gaines HO, Baue AE (1983) Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94:331–335Google Scholar
  27. 27.
    Ebong S, Call D, Nemzek.J, et al (1999) Immunopathologic alterations in murine models of sepsis of increasing severity. Infect Immun 67:6603–6610PubMedGoogle Scholar
  28. 28.
    Lush CW, Cepinskas G, Sibbald WJ, Kvietys PR (2001) Endothelial E- and P-selectin expression in iNOS- deficient mice exposed to polymicrobial sepsis. Am J Physiol Gastrointest Liver Physiol 280: G291–G297PubMedGoogle Scholar
  29. 29.
    Walley KR, Lukacs NW, Standiford TJ, et al. (1996) Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun 64:4733–4738PubMedGoogle Scholar
  30. 30.
    Hollenberg SM, Dumasius A, Easington C, Colilla SA, Neumann A, Parrillo JE (2001) Characterization of a hyperdynamic murine model of resuscitated sepsis using echocardiography. Am J Respir Crit Care Med 164:891–895PubMedGoogle Scholar
  31. 31.
    Godshall CJ, Scott MJ, Peyton JC, et al. (2002) Genetic background determines susceptibility during murine septic peritonitis. J Surg Res 102:45–49PubMedCrossRefGoogle Scholar
  32. 32.
    Stewart D, Fulton WB, Wilson C et al. (2002) Genetic contribution to the septic response in a mouse model. Shock 18:342–347PubMedCrossRefGoogle Scholar
  33. 33.
    Diodato MD, Knoferl MW, Schwacha MG, Bland KI, Chaudry IH (2001) Gender differences in the inflammatory response and survival following haemorrhage and subsequent sepsis. Cytokine 14:162–169PubMedCrossRefGoogle Scholar
  34. 34.
    Hyde SR, Stith RD, McCallum RE (1990) Mortality and bacteriology of sepsis following cecal ligation and puncture in aged mice. Infect Immun 58:619–624PubMedGoogle Scholar
  35. 35.
    Jimenez MF and Marshall JC (2001) Source control in the management of sepsis. Intensive Care Med 27 Suppl 1:S49–S62CrossRefGoogle Scholar
  36. 36.
    Bochud PY, Glauser MP, Calandra T (2001) Antibiotics in sepsis. Intensive Care Med 27 Suppi 1:S33–S48CrossRefGoogle Scholar
  37. 37.
    Newcomb D, Bolgos G, Green L, Remick DG (1998) Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity. Shock 10:110–117PubMedCrossRefGoogle Scholar
  38. 38.
    Vincent JL (2001) Hemodynamic support in septic shock. Intensive Care Med 27 Suppl 1:580-S92Google Scholar
  39. 39.
    Yang S, Chung CS, Ayala A, Chaudry IH, Wang P (2002) Differential alterations in cardiovascular responses during the progression of polymicrobial sepsis in the mouse. Shock 17:55–60PubMedCrossRefGoogle Scholar
  40. 40.
    Zuurbier CJ, Emons VM, Ince C (2002) Hemodynamics of anesthetized ventilated mouse models: aspects of anesthetics, fluid support, and strain. Am J Physiol Heart Circ Physiol 282:H2099–H2105PubMedGoogle Scholar
  41. 41.
    Hoit BD (2001) New approaches to phenotypic analysis in adult mice. J Mol Cell Cardiol 33:27–35PubMedCrossRefGoogle Scholar
  42. 42.
    Wilson MA, Chou MC, Spain DA et al. (1996) Fluid resuscitation attenuates early cytokine mRNA expression after peritonitis. J Trauma 41:622–627PubMedCrossRefGoogle Scholar
  43. 43.
    Schwarte LA, Zuurbier CJ, Ince C (2000) Mechanical ventilation of mice. Basic Res Cardiol 95:510–520PubMedCrossRefGoogle Scholar
  44. 44.
    Martin GS and Bernard GR (2001) Airway and lung in sepsis. Intensive Care Med 27 Suppl 1:S63–S79CrossRefGoogle Scholar
  45. 45.
    Arras M, Autenried P, Rettich A, et al. (2001) Optimization of intraperitoneal injection anesthesia in mice: drugs, dosages, adverse effects, and anesthesia depth. Comp Med 51:443–456PubMedGoogle Scholar
  46. 46.
    Imai T, Takahashi K, Masuo F, Goto F (1998) Anaesthesia affects outcome of sepsis in mice. Can J Anaesth 45:360–366PubMedCrossRefGoogle Scholar
  47. 47.
    Gades NM, Danneman PJ, Wixson SK, Tolley EA (2000) The magnitude and duration of the analgesic effect of morphine, butorphanol, and buprenorphine in rats and mice. Contemp Top Lab Anim Sci 39:8–13PubMedGoogle Scholar
  48. 48.
    Kluger MJ, Kozak W, Leon LR, Conn CA (1998) The use of knockout mice to understand the role of cytokines in fever. Clin Exp Pharmacol Physiol 25:141–144PubMedCrossRefGoogle Scholar
  49. 49.
    Redl H, Bahrami S, Schlag G, Traber DL (1993) Clinical detection of LPS and animal models of endotoxemia. Immunobiology 187:330–345PubMedCrossRefGoogle Scholar
  50. 50.
    Silva AT, Bayston KF, Cohen J (1990) Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock. J Infect Dis 162:421–427PubMedCrossRefGoogle Scholar
  51. 51.
    Noble WC (1965) The production of subcutaneous staphylococcal skin lesions in mice. Br J Exp Pathol 46:254–262PubMedGoogle Scholar
  52. 52.
    McConville JH, Snyder MJ, Calia FM, Hornick RB (1981) Model of intraabdominal abscess in mice. Infect Immun 31:507–509PubMedGoogle Scholar
  53. 53.
    Strand TA, Briles DE, Gjessing HK, et al. (2001) Pneumococcal pulmonary infection, septicaemia and survival in young zinc-depleted mice. Br J Nutr 86:301–306PubMedCrossRefGoogle Scholar
  54. 54.
    Kim MK, Zhou W, Tessier PR et al. (2002) Bactericidal Effect and Pharmacodynamics of Cethromycin (ABT-773) in a Murine Pneumococcal Pneumonia Model. Antimicrob Agents Chemother 46:3185–3192PubMedCrossRefGoogle Scholar
  55. 55.
    Wang E, Ouellet N, Simard M et al. (2001) Pulmonary and systemic host response to Streptococcus pneumoniae and Klebsiella pneumoniae bacteremia in normal and immunosuppressed mice. Infect Immun 69:5294–5304PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2004

Authors and Affiliations

  • Gerd Albuszies
    • 1
  1. 1.Sektion Anästhesiologische Pathophysiologie und VerfahrensentwicklungUniversitätsklinik für Anästhesiologie, Universität UlmGermany

Personalised recommendations